Acadia Pharmaceutical dips on downgrade to Hold at MLV

|By:, SA News Editor

Acadia Pharmaceuticals (ACAD -3.3%) slips after MLV & Co. cut the shares from Buy to Hold, but ups its price target from $18 to $20.

The firm says that although it was a "transformational" quarter for the company, the stock has reached fair value for now.